Next-Generation Sequencing Market Revenue Growth and Business Forecast 2026–2034

The global Next-Generation Sequencing Market is experiencing significant growth as healthcare providers, research institutions, and biotechnology companies increasingly adopt advanced genomic technologies. Next-generation sequencing (NGS) enables researchers to analyze large amounts of genetic information quickly and efficiently. It plays an important role in disease diagnosis, cancer research, drug discovery, personalized medicine, and genetic testing.

According to Fortune Business Insights, the global Next-Generation Sequencing Market size was valued at USD 10.44 billion in 2025. The market is projected to grow from USD 11.79 billion in 2026 to USD 38.34 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 15.88% during the forecast period. Increasing demand for precision medicine, advancements in genomic technologies, and rising investments in genetic research are expected to support market expansion.

Growing Demand for Personalized Medicine

The increasing adoption of personalized medicine is a major factor driving the Next-Generation Sequencing Market. Traditional treatment approaches often follow standardized methods, whereas personalized medicine uses individual genetic information to guide treatment decisions. NGS helps healthcare professionals identify genetic variations that may influence disease development and treatment responses.

The technology is particularly important in oncology, where genomic analysis can help identify mutations associated with different cancer types. Growing interest in targeted therapies and individualized treatment strategies is encouraging healthcare providers to incorporate genomic testing into clinical practice.

Increasing Applications in Cancer Research and Genetic Testing

The rising global burden of cancer and inherited diseases is creating opportunities for NGS technologies. Researchers use sequencing methods to study genetic mutations, identify disease-associated biomarkers, and understand biological changes linked to different medical conditions.

NGS is also increasingly used for reproductive health testing, rare disease diagnosis, infectious disease research, and population genomics. Its ability to analyze multiple genes simultaneously makes it valuable for applications requiring comprehensive genetic information. Continued research and improvements in sequencing accuracy may further expand its clinical and scientific applications.

For detailed market insights : https://www.fortunebusinessinsights.com/industry-reports/next-generation-sequencing-ngs-market-101000 

Technology Analysis

Based on technology, the Next-Generation Sequencing Market includes sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and other technologies.

• Sequencing by Synthesis: This technology identifies DNA sequences by detecting nucleotides as they are incorporated into a growing DNA strand. It is widely used in genomic research and clinical applications.

• Ion Semiconductor Sequencing: This method detects changes in hydrogen ion concentration during DNA synthesis. Its applications include targeted sequencing and genetic analysis.

• Single-Molecule Real-Time Sequencing: This technology analyzes DNA molecules individually and supports long-read sequencing applications. It is useful for studying complex genomic regions.

• Nanopore Sequencing: Nanopore technology identifies DNA or RNA sequences as molecules pass through microscopic pores. Its portability and real-time sequencing capabilities support various research applications.

• Others: Other sequencing technologies contribute to specialized genomic research and diagnostic requirements.

Product and Service Analysis

The market includes sequencing platforms, consumables, and services. Sequencing platforms are essential instruments used to process genetic samples and generate sequencing data. Improvements in instrument performance, throughput, and automation are influencing purchasing decisions among laboratories and research institutions.

Consumables, including reagents, flow cells, and sample preparation materials, represent an important part of sequencing operations. Meanwhile, sequencing services support organizations that do not have the infrastructure or expertise required to conduct genomic analysis internally. Growing outsourcing activities may create additional opportunities for specialized service providers.

Application Analysis

The Next-Generation Sequencing Market serves several important applications, including diagnostics, drug discovery and development, personalized medicine, agricultural and animal research, and other research activities.

Diagnostics represents a significant application area because NGS supports the identification of genetic abnormalities, inherited disorders, and cancer-related mutations. Pharmaceutical companies also use sequencing technologies during drug discovery and development to investigate disease mechanisms and identify potential therapeutic targets.

Personalized medicine is another expanding application, as genomic information helps guide treatment selection. Agricultural and animal research applications include crop improvement, genetic diversity studies, and disease resistance research.

Regional Analysis

North America dominated the Next-Generation Sequencing Market with a 56.01% share in 2025. The region benefits from advanced healthcare infrastructure, substantial investments in genomic research, established biotechnology companies, and growing adoption of precision medicine. Strong research capabilities and the presence of specialized laboratories also support regional demand.

Europe represents an important market due to investments in life sciences research, genomic medicine, and healthcare innovation. Increasing use of genetic testing and collaborations between research institutions are supporting market development.

Asia Pacific is expected to offer growth opportunities through expanding healthcare infrastructure, increasing biotechnology investments, and rising awareness of genetic testing. Countries such as China, Japan, and India are strengthening their genomic research capabilities.

South America is gradually developing its genomics capabilities through healthcare modernization, academic research, and investments in molecular diagnostics. Improved access to sequencing technologies may support future growth.

The Middle East & Africa may experience increasing adoption as healthcare facilities expand advanced diagnostic capabilities and governments invest in biotechnology and medical research.

Competitive Landscape

The Next-Generation Sequencing Market is characterized by competition among genomic technology developers, biotechnology companies, and specialized sequencing service providers. Market participants focus on improving sequencing accuracy, reducing testing costs, increasing throughput, and developing advanced bioinformatics solutions.

Companies also invest in research and development to improve instrument capabilities and expand clinical applications. Strategic collaborations, product launches, and technological advancements remain important competitive approaches in this industry.

Recent Industry Developments

Recent industry trends emphasize the development of long-read sequencing, improved sequencing platforms, and integrated genomic data analysis solutions. These advancements are helping researchers investigate complex genetic variations and obtain more comprehensive genomic information.

Artificial intelligence and machine learning are also becoming increasingly relevant to genomic data analysis. These technologies can help researchers process large datasets, identify patterns, and improve the interpretation of sequencing results. Growing interest in clinical genomics is further encouraging the development of solutions designed for healthcare applications.

Get Free Sample PDF:  https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/next-generation-sequencing-ngs-market-101000 

Future Outlook

The global Next-Generation Sequencing Market is expected to experience strong growth through 2034, supported by increasing demand for personalized medicine, expanding cancer research, and advancements in genomic technologies. According to Fortune Business Insights, the market is projected to reach USD 38.34 billion by 2034, growing at a CAGR of 15.88% during 2026–2034.

Future opportunities will depend on improvements in sequencing accuracy, affordability, data interpretation, and clinical integration. The expansion of genomic research and precision healthcare is expected to strengthen the role of next-generation sequencing across diagnostics, pharmaceutical development, and biotechnology research. As sequencing technologies become more accessible, their adoption is likely to increase across healthcare and scientific research environments.

Related Report

Uncover Japan’s Market Trends - Explore the Latest - Next-Generation Sequencing Market - Insights